DNB Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Dun & Bradstreet to Clearlake Capital

Core Viewpoint - Wohl & Fruchter LLP is investigating the fairness of the proposed sale of Dun & Bradstreet Holdings, Inc. (DNB) to Clearlake Capital for $9.15 per share, which is below the price targets set by multiple Wall Street analysts and significantly lower than DNB's 52-week high of $12.95 per share, indicating a potentially opportunistic deal [1][3]. Group 1 - The sale price of $9.15 per share is below the price targets of at least seven Wall Street analysts, suggesting concerns about the fairness of the offer [1][3]. - The proposed sale price is significantly lower than DNB's 52-week high of $12.95 per share, raising questions about the motivations behind the deal [1][3]. - Wohl & Fruchter LLP is examining whether the DNB Board of Directors acted in the best interests of shareholders and if all material information regarding the transaction has been disclosed [4]. Group 2 - Analysts have set various price targets for DNB, with the highest being $17.00 per share from Deutsche Bank, followed by targets of $15.00, $14.00, $12.00, $11.00, and $10.00 from other firms [5]. - The investigation aims to determine if the agreed sale price is fair to DNB shareholders [4]. - Wohl & Fruchter LLP has a history of representing investors in litigation related to corporate misconduct, recovering significant damages for investors [4].